vs

Side-by-side financial comparison of Forafric Global PLC (AFRI) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $159.7M, roughly 1.2× Forafric Global PLC). REPLIGEN CORP runs the higher net margin — 6.7% vs -7.5%, a 14.3% gap on every dollar of revenue. REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $146.0K).

Forafric Global PLC is an Africa-focused agribusiness operating across the full agricultural value chain, covering staple food production, processing, and distribution. Its core markets are North and West Africa, supplying grain, vegetable oil and essential food commodities to consumer, retail and industrial clients.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

AFRI vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.2× larger
RGEN
$197.9M
$159.7M
AFRI
Higher net margin
RGEN
RGEN
14.3% more per $
RGEN
6.7%
-7.5%
AFRI
More free cash flow
RGEN
RGEN
$17.4M more FCF
RGEN
$17.6M
$146.0K
AFRI

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
AFRI
AFRI
RGEN
RGEN
Revenue
$159.7M
$197.9M
Net Profit
$-12.0M
$13.3M
Gross Margin
10.7%
52.5%
Operating Margin
-2.5%
9.0%
Net Margin
-7.5%
6.7%
Revenue YoY
13.6%
Net Profit YoY
143.9%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AFRI
AFRI
RGEN
RGEN
Q4 25
$197.9M
Q3 25
$188.8M
Q2 25
$159.7M
$182.4M
Q1 25
$169.2M
Q4 24
$174.1M
Q3 24
$154.9M
Q2 24
$145.6M
$154.1M
Q1 24
$151.3M
Net Profit
AFRI
AFRI
RGEN
RGEN
Q4 25
$13.3M
Q3 25
$14.9M
Q2 25
$-12.0M
$14.9M
Q1 25
$5.8M
Q4 24
$-30.3M
Q3 24
$-654.0K
Q2 24
$-8.6M
$3.3M
Q1 24
$2.1M
Gross Margin
AFRI
AFRI
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
10.7%
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
9.4%
49.8%
Q1 24
49.5%
Operating Margin
AFRI
AFRI
RGEN
RGEN
Q4 25
9.0%
Q3 25
8.9%
Q2 25
-2.5%
7.6%
Q1 25
3.9%
Q4 24
-17.7%
Q3 24
-5.1%
Q2 24
-0.9%
1.0%
Q1 24
1.3%
Net Margin
AFRI
AFRI
RGEN
RGEN
Q4 25
6.7%
Q3 25
7.9%
Q2 25
-7.5%
8.2%
Q1 25
3.4%
Q4 24
-17.4%
Q3 24
-0.4%
Q2 24
-5.9%
2.2%
Q1 24
1.4%
EPS (diluted)
AFRI
AFRI
RGEN
RGEN
Q4 25
$0.24
Q3 25
$0.26
Q2 25
$0.26
Q1 25
$0.10
Q4 24
$-0.55
Q3 24
$-0.01
Q2 24
$0.06
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AFRI
AFRI
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$12.2M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$5.3M
$2.1B
Total Assets
$246.1M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AFRI
AFRI
RGEN
RGEN
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$12.2M
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$16.4M
$809.1M
Q1 24
$780.6M
Total Debt
AFRI
AFRI
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
$18.4M
Q1 24
Stockholders' Equity
AFRI
AFRI
RGEN
RGEN
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$5.3M
$2.1B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$16.3M
$2.0B
Q1 24
$2.0B
Total Assets
AFRI
AFRI
RGEN
RGEN
Q4 25
$2.9B
Q3 25
$2.9B
Q2 25
$246.1M
$2.9B
Q1 25
$2.9B
Q4 24
$2.8B
Q3 24
$2.8B
Q2 24
$287.1M
$2.9B
Q1 24
$2.8B
Debt / Equity
AFRI
AFRI
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
1.13×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AFRI
AFRI
RGEN
RGEN
Operating Cash FlowLast quarter
$706.0K
$25.7M
Free Cash FlowOCF − Capex
$146.0K
$17.6M
FCF MarginFCF / Revenue
0.1%
8.9%
Capex IntensityCapex / Revenue
0.4%
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AFRI
AFRI
RGEN
RGEN
Q4 25
$25.7M
Q3 25
$48.1M
Q2 25
$706.0K
$28.6M
Q1 25
$15.0M
Q4 24
$39.2M
Q3 24
$49.3M
Q2 24
$10.5M
$42.2M
Q1 24
$44.7M
Free Cash Flow
AFRI
AFRI
RGEN
RGEN
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$146.0K
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$6.4M
$37.4M
Q1 24
$36.4M
FCF Margin
AFRI
AFRI
RGEN
RGEN
Q4 25
8.9%
Q3 25
23.0%
Q2 25
0.1%
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
4.4%
24.3%
Q1 24
24.0%
Capex Intensity
AFRI
AFRI
RGEN
RGEN
Q4 25
4.1%
Q3 25
2.5%
Q2 25
0.4%
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
2.8%
3.1%
Q1 24
5.5%
Cash Conversion
AFRI
AFRI
RGEN
RGEN
Q4 25
1.93×
Q3 25
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AFRI
AFRI

Sales to external customers, Total$159.7M100%
Couscous & Pasta$934.0K1%
Soft Wheat$393.0K0%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons